Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of mimecan in the assessment of heart failure

Use of mimecan in the assessment of heart failure

US Patent 10234462 · Granted Mar 19, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stro2025
IGFBP7 ratio for HFpEF2025
Agitator for a surface treatment apparatus and a surface treatment apparatus hav2024
Biomarkers for risk assessment and treatment monitoring in heart failure patient2024
Biomarkers for risk assessment and treatment monitoring in heart failure patient2024
Circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protei2024
IGFBP-7 as a marker of preeclampsia2024
IGFBP-7 as a marker of preeclampsia2024
GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients2023
Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fi2023
Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fi2023
Marker for statin treatment stratification in heart failure2022